Biomedical company conceived in London and founded in Italy
IBD is an innovative SME, a manufacturer of biomedical devices conceived in London and founded in Italy in 2014.
Led by a team with more than 10 years of experience in medical device design, IBD has so far raised over € 1 million in business angel funding and grants.
It is now facing a new round of funding and is constantly looking for investors who believe in the values and goals that drive IBD.
Our
Vision
IBD considers the Reverse Innovation of medical devices the key to making quality health care accessible to the whole world .
Our
Mission
Our mission is tackling health problems through the application of the principles of reverse innovation.
We observe the technological limitations and clinical needs existing in the global healthcare environment to create the best solution in terms of safety and efficacy , optimization of costs, and usability .
Our story
2014
Development Activities
The MyDial technological concept has been formulated.
Foundation
In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).
Development Activities
The first prototype of MyDial was developed using a PC-controlled data acquisition platform.
2015
Development Activities
IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT
2017
2018
POR FESR call for innovative Startups
IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.
Third Prototype Tested and Validated
The third protype of MyDial has been tested and validated in vitro.
Industrialization and Certification process
Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.
Seals of Excellence Horizon 2020
Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419
2019
Biorespira patent and registration in 20 countries
Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.
Biorespira records illustrious names among its sales
Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).
First participation in Medica 2021
IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.
Start of work on new headquarters
2021
2022
IBD flies to Dubai for Arab Health 2022
First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.
Our Story
2014
Development Activities
The MyDial technological concept has been formulated.
Foundation
In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).
2015
Development Activities
The first prototype of MyDial was developed using a PC-controlled data acquisition platform.
2017
Development Activities
IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT
2018
POR FESR call for innovative Startups
IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.
Third Prototype Tested and Validated
The third protype of MyDial has been tested and validated in vitro.
2019
Industrialization and Certification process
Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.
Seals of Excellence Horizon 2020
Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419
2021
Biorespira patent and registration in 20 countries
Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.
Biorespira records illustrious names among its sales
Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).
First participation in Medica 2021
IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.
Start of work on new headquarters
Work has started on the new headquarters of IBD Italian Biomedical Devices. The new operational headquarters will be developed on 2 floors for a total area of 1300 square meters. The structure was conceived with the aim of creating the perfect environment for the hybrid working of the future, including various areas for meetings, meetings and relaxation areas.
2022
IBD flies to Dubai for Arab Health 2022
First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.
Our Story
2014
Development Activities
The MyDial technological concept has been formulated.
Foundation
In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).
2015
Development Activities
The first prototype of MyDial was developed using a PC-controlled data acquisition platform.
2017
Development Activities
IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT
2018
POR FESR call for innovative Startups
IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.
Third Prototype Tested and Validated
The third protype of MyDial has been tested and validated in vitro.
2019
Seals of Excellence Horizon 2020
Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419
2021
Biorespira patent and registration in 20 countries
Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.
Biorespira records illustrious names among its sales
Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).
First participation in Medica 2021
IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.
Start of work on new headquarters
Work has started on the new headquarters of IBD Italian Biomedical Devices.
The new operational headquarters will be developed on 2 floors for a total area of 1300 square meters.
The structure was conceived with the aim of creating the perfect environment for the hybrid working of the future, including various areas for meetings, meetings and relaxation areas.
2022
IBD flies to Dubai for Arab Health 2022
First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.